Jon Snodgres - 16 Aug 2022 Form 4 Insider Report for REPLIGEN CORP (RGEN)

Signature
/s/ Kimberly Brown (Attorney in Fact)
Issuer symbol
RGEN
Transactions as of
16 Aug 2022
Net transactions value
-$1,222,229
Form type
4
Filing time
17 Aug 2022, 16:41:45 UTC
Previous filing
02 Aug 2022
Next filing
11 Oct 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RGEN Common Stock Options Exercise $262,347 +3,047 +8.2% $86.10 40,234 16 Aug 2022 Direct
transaction RGEN Common Stock Options Exercise $209,113 +970 +2.4% $215.58 41,204 16 Aug 2022 Direct
transaction RGEN Common Stock Sale $1,086,105 -4,298 -10% $252.70 36,906 16 Aug 2022 Direct F1
transaction RGEN Common Stock Sale $607,584 -2,400 -6.5% $253.16 34,506 16 Aug 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RGEN Stock Option (Right to Buy) Options Exercise $0 +3,047 $0.000000 1,524 16 Aug 2022 Common Stock 3,047 $86.10 Direct F2
transaction RGEN Stock Option (Right to Buy) Options Exercise $0 +970 +100% $0.000000 1,940 16 Aug 2022 Common Stock 970 $215.58 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 $252.70 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $252.16 to $253.11, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F2 1,524 shares vest and become exercisable on 2/27/2023.
F3 Shares vest and become exercisable as follows: 970 shares on 2/24/2023 and 970 shares on 2/24/2024.